Patents by Inventor Joel Sequeira

Joel Sequeira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent number: 6057307
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: March 1, 1999
    Date of Patent: May 2, 2000
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Use of mometasone furoate for treating lower airway passage and lung diseases
    Patent number: 5889015
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: August 14, 1997
    Date of Patent: March 30, 1999
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Stable antiandrogenic gel composition
    Patent number: 5879711
    Abstract: Pharmaceutical compositions for the topical treatment of androgen-related conditions, e.g., acne in humans containing an amount of the compound represented by formula II effective for the topical treatment of the androgen-related conditions, e.g., acne ##STR1## dissolved in an alcohol-water solvent system, such as ethanol-water ?97.6:2.4(w/w)! and having an apparent pH in the range of about 3.5 to 4.5, and containing a gelling agent are disclosed.
    Type: Grant
    Filed: November 7, 1997
    Date of Patent: March 9, 1999
    Inventors: Joel A. Sequeira, Fernand Labrie, Shanshank Mahashabde, Nicholas DeAngelis, Yves Merand, Marc Fournier
  • Use of mometasone furoate for treating upper airway passage diseases
    Patent number: 5837699
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Grant
    Filed: March 20, 1997
    Date of Patent: November 17, 1998
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Francis M. Cuss, Keith B. Nolop, Imtiaz A. Chaudry, Nagamani Nagabhushan, James E. Patrick, Mitchell Cayen
  • Stable hydrated cephalosporin dry powder for oral suspension formulation
    Patent number: 5599557
    Abstract: A dry hydrated cephalosporin, e.g. ceftibuten having about 7 to 14% by weight of water, powder formulation, pharmaceutical compositions in the form of an oral suspension dosage form and a method of making the dry powder formulations are disclosed.
    Type: Grant
    Filed: October 27, 1994
    Date of Patent: February 4, 1997
    Assignee: Schering Corporation
    Inventors: Donald A. Johnson, Lorraine Wearley, Rebecca Galeos, Joel A. Sequeira
  • Non-chlorofluorocarbon aerosol formulations
    Patent number: 5474759
    Abstract: Aerosol formulations substantially free of chlorofluorocarbons for oral and/or nasal administration are described. The formulations comprise 1,1,1,2,3,3,3-heptafluoropropane, a medicament, optionally an excipient and optionally a surfactant. Methods of treatment utilizing the formulations are also described.
    Type: Grant
    Filed: December 9, 1993
    Date of Patent: December 12, 1995
    Assignee: Schering Corporation
    Inventors: Julianne Fassberg, Joel A. Sequeira, Imtiaz A. Chaudry, Michael Kopcha
  • Stable cream and lotion bases for lipophilic drug compositions
    Patent number: 5422361
    Abstract: A cosmetically elegant, physically and chemically stable base in the form of an oil-in-water emulsion for use in cream and lotion lipophilic drug containing- pharmaceutical compositions containing at least one lipophilic drug and an effective amount of N-methyl-2-pyrrolidone is disclosed.
    Type: Grant
    Filed: June 12, 1992
    Date of Patent: June 6, 1995
    Assignee: Schering Corporation
    Inventors: Farah J. Munayyer, Joel A. Sequeira
  • Sustained release oral suspensions
    Patent number: 5186930
    Abstract: Stable sustained release wax- and polymer-coated drug-ion exchange resin complexes especially useful in preparing oral suspensions are disclosed.
    Type: Grant
    Filed: December 19, 1990
    Date of Patent: February 16, 1993
    Assignee: Schering Corporation
    Inventors: Patricia W. Kogan, Edward M. Rudnic, Joel A. Sequeira, Imtiaz A. Chaudry
  • Sustained release oral suspensions
    Patent number: 4999189
    Abstract: Stable sustained release wax- and polymer-coated drug-ion exchange resin complexes especially useful in preparing oral suspensions are disclosed.
    Type: Grant
    Filed: November 14, 1988
    Date of Patent: March 12, 1991
    Assignee: Schering Corporation
    Inventors: Patricia W. Kogan, Edward M. Rudnic, Joel A. Sequeira, Imtiaz A. Chaudry
  • Transdermal delivery of loratadine
    Patent number: 4910205
    Abstract: A pharmaceutical composition for the transdermal delivery of loratadine comprising isopropyl myristate and rosemary oil and the method of using such a composition for the treatment of allergic reactions are disclosed.
    Type: Grant
    Filed: May 2, 1988
    Date of Patent: March 20, 1990
    Assignee: Schering Corporation
    Inventors: Patricia W. Kogan, Joel A. Sequeira
  • Transdermal delivery of azatidine
    Patent number: 4834980
    Abstract: Compositions for the transdermal delivery of azatadine and the use of such compositions in the treatment of allergic reactions are disclosed.
    Type: Grant
    Filed: September 28, 1987
    Date of Patent: May 30, 1989
    Assignee: Schering Corporation
    Inventor: Joel A. Sequeira
  • Mometasone furoate anti-inflammatory cream composition using hexylene glycol
    Patent number: 4808610
    Abstract: Disclosed is an elegant, stable, self-preserving cream formulation containing mometasone furoate, 9.alpha., 21-dichloro-16.alpha.-methyl-1,4-pregnadiene-11.beta.,17.alpha.-diol-3,20- dione-17-(2'-furoate), useful as a topical anti-inflammatory product.
    Type: Grant
    Filed: October 2, 1986
    Date of Patent: February 28, 1989
    Assignee: Schering Corporation
    Inventors: Farah J. Munayyer, Joel A. Sequeira
  • Steroid lotion
    Patent number: 4775529
    Abstract: An improved lotion formulation for the topical administration of corticosteroids in a hydro-alcoholic base containing propylene glycol.
    Type: Grant
    Filed: May 21, 1987
    Date of Patent: October 4, 1988
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Farah J. Munayyer, Rebecca Galeos
  • Clotrimazole cream
    Patent number: 4775678
    Abstract: An oil-in-water cream or lotion emulsion formulation containing clotrimazole having improved antifungal properties containing various amounts of clotrimazole, petrolatum, cetearyl alcohol, propylene glycol, and ceteth-20, with or without other additional ingredients.
    Type: Grant
    Filed: May 8, 1986
    Date of Patent: October 4, 1988
    Assignee: Schering Corporation
    Inventors: Ching-Chiang Su, Joel A. Sequeira
  • Novel vaginal suppository
    Patent number: 4765978
    Abstract: An antifungal vaginal suppository is disclosed comprising cis-2-(1H-imidazolylmethyl)-3-(2',6'-difluorobenzyloxy)-2,3-dihydro-5-fluo robenzo[b]thiophene in a suppository base containing biocompatible polymers, a surfactant and an absorbent in a vegetable oil phase.
    Type: Grant
    Filed: December 16, 1986
    Date of Patent: August 23, 1988
    Assignee: Schering Corporation
    Inventors: Syed E. Abidi, Joel A. Sequeira
  • Compositions and method for enhancement of the transdermal flux of albuterol with a combination of 1-dodecyl-azacyclopheptan-2-one and urea
    Patent number: 4699777
    Abstract: A topical albuterol composition having superior transdermal flux containing various amounts of albuterol, 1-dodecyl-azacycloheptan-2-one and urea in a non-aqueous environment. The enhancement observed in albuterol skin penetration indicates that a therapeutically effective amount of albuterol can be delivered through skin using these formulations. The compositions can be administered topically as a cream, lotion or via a transdermal device.
    Type: Grant
    Filed: August 21, 1985
    Date of Patent: October 13, 1987
    Assignee: Schering Corporation
    Inventors: Michael A. Zupon, Joel A. Sequeira
  • Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
    Patent number: 4499108
    Abstract: Albuterol sulfate syrups that are pleasant-tasting and stable upon prolonged storage.
    Type: Grant
    Filed: June 8, 1983
    Date of Patent: February 12, 1985
    Assignee: Schering Corporation
    Inventors: Joel A. Sequeira, Michael A. Zupon
  • Betamethasone dipropionate cream
    Patent number: 4489071
    Abstract: An elegant topical cream composition, containing betamethasone dipropionate, for the treatment of inflammation.
    Type: Grant
    Filed: December 9, 1983
    Date of Patent: December 18, 1984
    Assignee: Schering Corporation
    Inventors: Richard K. Florance, Joel A. Sequeira
  • Interferon kit
    Patent number: 4469228
    Abstract: Disclosed is a kit for preparing a lyophilized alpha interferon gel formulation suitable for topical administration.
    Type: Grant
    Filed: May 31, 1983
    Date of Patent: September 4, 1984
    Assignee: Schering Corporation
    Inventors: Michael A. Zupon, Joel A. Sequeira, Alan S. Kirschner, Pui-Ho Yuen